Clinical Trials Directory

Trials / Completed

CompletedNCT04284930

Comparison of Local Anesthetic Infusion Pump Versus Depofoam Bupivacaine for Pain Management

Prospective, Randomized, Controlled Comparison of Local Anesthetic Infusion Pump Versus DepoFoam Bupivacaine For Pain Management After Unilateral Deep Inferior Epigastic Perforator Free Flap Reconstruction

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
21 (actual)
Sponsor
The Cleveland Clinic · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Effective post surgical pain control in patients undergoing unilateral deep inferior epigastric perforator (DIEP) free flap reconstruction.

Detailed description

Critical to patient recovery, and can contribute to faster patient mobilization, shorter hospital stays and reduced health care costs. The administration of local anesthetics via wound infiltration is standard of care and an effective practice for post surgical pain management, However this method only provides relatively brief analgesia, usually lasting only 12 hours. Other FDA approved delivery systems using an indwelling fusion pump catheter (On-Q pump) are currently being used in our practice and may be used to extend the duration of action of locally administered analgesia by continuously infusing anesthetic into the wound. Alternatively, a depot form of bupivacaine has been FDA approved and currently used to deliver a single dose administered via wound infiltration for prolonged analgesia by allowing for the diffusion of the drug over an extended period of time. Both of these products are used as a standard practice during DIEP free flap reconstructions. However, no studies compare the efficacy of these two methods patients undergong unilateral DIEP flap reconstructions has been done in a prospective, randomized control manner.

Conditions

Interventions

TypeNameDescription
DRUGDepobupivacainesurgeons receive schematic for injection of Depobupivacaine. Subjects receive an injection of 166mg depobupivacaine. Injection on either side of the suture line, injected directly into the fascia.
DRUGOnQ pumpgroup 2: Surgeons receive instruction sheet with specific placement of catheter. All patients have two OnQ soaker catheters installed into abdominal donor site before donor closure.
DRUG0.25% Bupivacainegroup 3: given 0.25% bupivacaine without epinephrine between internal oblique and transverse abdominal muscle.

Timeline

Start date
2016-02-01
Primary completion
2017-11-01
Completion
2017-11-01
First posted
2020-02-26
Last updated
2021-01-07
Results posted
2021-01-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04284930. Inclusion in this directory is not an endorsement.